You are here


At Loyola's Cardinal Bernardin Cancer Center, we bring together the expertise and skills of physicians from several different specialties to design a care plan that is tailored to our patients’ needs. We understand that a diagnosis of leukemia/lymphoma can be overwhelming for our patients and their loved ones, and we believe in a “whole-person” approach that provides psychosocial support services in concert with leading-edge treatments and therapies.

Depending on the type of leukemia/lymphoma you have, you may be treated with chemotherapy, targeted therapy, immunotherapy, radiation or stem cell transplants. Sometimes a combination of therapies provides the most optimal chance of a good outcome. Your treatment plan will be the product of an entire team of specialists who are dedicated to your health and well-being.

Targeted therapy uses drugs that take aim at specific parts of cancer cells. These drugs are taken as pills and have milder side effects than chemotherapy drugs. Immunotherapy uses man-made substances, normally made by the immune system, that kill cancer cells, retard their growth or strengthen the patient's immune system to attack cancer cells.

Some patients also will require stem cell transplants to restore the bone marrow that may have been damaged by necessary therapies, such as chemotherapy and radiation, or that may have been depleted by the disease itself. Bone marrow is essential because it makes new blood cells and fights infections. Stem cells can be obtained from a matching donor (allogeneic transplant) or from the patient’s own bone marrow (autologous transplant). These infection-fighting cells also can be obtained from donated umbilical cord blood. These replacement cells will restore bone marrow function. Loyola's Bone Marrow Transplantation Program is the largest in Illinois, having performed more than 1,900 transplants to date. It is well documented by the American Society of Clinical Oncologists that centers that perform the greatest number of transplants have the highest survival rates.

Loyola’s team is actively involved in research, providing patients opportunities to participate in promising clinical trials that are not available at community hospitals. We encourage patients and families to see us as soon as possible after a cancer diagnosis because we know that the earlier a patient receives treatment, the better the chances for good outcomes.

We are a large team with one primary concern: our patients. Our multidisciplinary transplant team includes physicians, nurses, transplant coordinators, case managers, dietitians, social workers, chaplains and a clinical psychologist. Our complementary and supportive care includes access to such services as psychotherapy services, nutritional counseling, massage therapy, spa services and pain management. We are dedicated to going beyond the treatment of the disease and caring for the issues that affect your life, your work and your family.

Contact Us

For an appointment or for more information about Leukemia/Lymphoma, call (708) CAN-HELP.